Recently while doing a study to gauge the investment attractiveness of certain Indian states for a global auto manufacturing company I realized that the biggest hurdle was that most of these states were facing a severe energy deficit. In fact India has a power deficit of around 10 to 17% where, a third
|
||||||||||||||||||||||||||
|
When India based biotechnology firm Biocon entered into an agreement with Pfizer recently, a lot of hype was generated on biosimilars being the next big cash cow for India. Biocon struck this deal to introduce biosimilar insulin products in India – the second diabetes capital in the world after China. Biosimilars[1] are generic impersonation of biotech Recently, I read an article that reported – the Australian Competition and Consumer Commission (ACCC) blocked an acquisition bid by an Australian major wealth management company, NAB over its rival AXA Australia. ACCC, the competition regulator, is an agency that enforces the Trade Practices Act which covers unfair market practices, mergers and acquisitions of companies, If I was asked this question only 5 years ago, I would have hesitated in responding. Competitive intelligence was “nice to have”, but few companies were ready to commit resources and budgets for it. I recently had the opportunity to interact with several senior CI practitioners from companies operating in various sectors such as IT, BFSI, As a competitive intelligence professional in an emerging economy, documentation is my pet peeve. Business and economic growth in developing economies will be higher with greater transparency and information, all other things remaining unchanged. The argument is simple. Under-documentation is a big impediment to decision making. It makes informed decision making very expensive. This means that |
|
|||||||||||||||||||||||||
|
Copyright © 2012 ValueNotes Database Pvt. Ltd.|All Rights Reserved|Terms of Use |
||||||||||||||||||||||||||
Recent Comments